Obesity-induced miR-15b is linked causally to the development of insulin resistance through the repression of the insulin receptor in hepatocytes

Molecular Nutrition and Food Research

Volumn 59, Issue 11, 2015, Pages 2303-2314

  Yang, Won Mo ^a   Jeong, Hyo Jin ^a   Park, Se Whan ^a   Lee, Wan ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

INSR; Insulin resistance; IRS 1; MicroRNA; MiR 15b; Palmitate; Saturated fatty acid

Indexed keywords

INSULIN RECEPTOR; MICRORNA; MIRN15 MICRORNA, MOUSE; PALMITIC ACID DERIVATIVE;

ANIMAL; C57BL MOUSE; GENETICS; HEP-G2 CELL LINE; HUMAN; INSULIN RESISTANCE; LIPID DIET; LIVER; LIVER CELL; MALE; METABOLISM; MOUSE; OBESITY; PHYSIOLOGY;

ANIMALS; DIET, HIGH-FAT; HEP G2 CELLS; HEPATOCYTES; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; OBESITY; PALMITATES; RECEPTOR, INSULIN;

EID: 84939174629     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500107     Document Type: Article

References (49)

1. Kahn, S. E., Hull, R. L., Utzschneider, K. M., Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444, 840-846.
2. Fock, K. M., Khoo, J., Diet and exercise in management of obesity and overweight. J. Gastroenterol. Hepatol. 2013, 28 (Suppl 4), 59-63.
3. Perry, R. J., Samuel, V. T., Petersen, K. F., Shulman, G. I., The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014, 510, 84-91.
4. Samuel, V. T., Shulman, G. I., Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148, 852-871.
5. Shulman, G. I., Cellular mechanisms of insulin resistance. J. Clin. Invest. 2000, 106, 171-176.
6. Saltiel, A. R., Pessin, J. E., Insulin signaling pathways in time and space. Trends Cell Biol. 2002, 12, 65-71.
7. Boren, J., Taskinen, M. R., Olofsson, S. O., Levin, M., Ectopic lipid storage and insulin resistance: a harmful relationship. J. Intern. Med. 2013, 274, 25-40.
8. Capurso, C., Capurso, A., From excess adiposity to insulin resistance: the role of free fatty acids. Vascul. Pharmacol. 2012, 57, 91-97.
9. Joshi, R. L., Lamothe, B., Cordonnier, N., Mesbah, K. et al., Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 1996, 15, 1542-1547.
10. Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F. et al., Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell 2000, 6, 87-97.
11. Stumvoll, M., Goldstein, B. J., van Haeften, T. W., Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365, 1333-1346.
12. Taylor, S. I., Accili, D., Imai, Y., Insulin resistance or insulin deficiency. Which is the primary cause of niddm? Diabetes 1994, 43, 735-740.
13. Pillai, R. S., Bhattacharyya, S. N., Filipowicz, W., Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 2007, 17, 118-126.
14. Bartel, D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009, 136, 215-233.
15. Mersey, B. D., Jin, P., Danner, D. J., Human microRNA (mir29b) expression controls the amount of branched chain alpha-ketoacid dehydrogenase complex in a cell. Hum. Mol. Genet. 2005, 14, 3371-3377.
16. Park, S. Y., Jeong, H. J., Yang, W. M., Lee, W., Implications of microRNAs in the pathogenesis of diabetes. Arch. Pharm. Res. 2013, 36, 154-166.
17. Hennessy, E., O'Driscoll, L., Molecular medicine of microRNAs: structure, function and implications for diabetes. Expert. Rev. Mol. Med. 2008, 10, e24.
18. Kornfeld, J. W., Baitzel, C., Konner, A. C., Nicholls, H. T. et al., Obesity-induced overexpression of mir-802 impairs glucose metabolism through silencing of hnf1b. Nature 2013, 494, 111-115.
19. Yang, W. M., Jeong, H. J., Park, S. Y., Lee, W., Induction of mir-29a by saturated fatty acids impairs insulin signaling and glucose uptake through translational repression of irs-1 in myocytes. FEBS Lett. 2014, 588, 2170-2176.
20. Yang, W. M., Jeong, H. J., Park, S. Y., Lee, W., Saturated fatty acid-induced mir-195 impairs insulin signaling and glycogen metabolism in hepg2 cells. FEBS Lett. 2014, 588, 3939-3946.
21. Chen, Z., Sun, X., Shen, S., Zhang, H. et al., Wedelolactone, a naturally occurring coumestan, enhances interferon-gamma signaling through inhibiting stat1 protein dephosphorylation. J. Biol. Chem. 2013, 288, 14417-14427.
22. Zhang, Y., Cheng, X., Lu, Z., Wang, J. et al., Upregulation of mir-15b in nafld models and in the serum of patients with fatty liver disease. Diabetes Res. Clin. Pract. 2013, 99, 327-334.
23. Finnerty, J. R., Wang, W. X., Hebert, S. S., Wilfred, B. R. et al., The mir-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases. J. Mol. Biol. 2010, 402, 491-509.
24. Maudet, C., Mano, M., Sunkavalli, U., Sharan, M. et al., Functional high-throughput screening identifies the mir-15 microRNA family as cellular restriction factors for salmonella infection. Nat. Commun. 2014, 5, 4718.
25. Hirano, T., Condensins: organizing and segregating the genome. Curr. Biol. 2005, 15, R265-R275.
26. Zhou, B., Yuan, T., Liu, M., Liu, H. et al., Overexpression of the structural maintenance of chromosome 4 protein is associated with tumor de-differentiation, advanced stage and vascular invasion of primary liver cancer. Oncol. Rep. 2012, 28, 1263-1268.
27. Baskerville, S., Bartel, D. P., Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005, 11, 241-247.
28. Xia, L., Zhang, D., Du, R., Pan, Y. et al., Mir-15b and mir-16 modulate multidrug resistance by targeting bcl2 in human gastric cancer cells. Int. J. Cancer 2008, 123, 372-379.
29. Satzger, I., Mattern, A., Kuettler, U., Weinspach, D. et al., Microrna-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int. J. Cancer 2010, 126, 2553-2562.
30. Chen, G. Q., Lian, W. J., Wang, G. M., Wang, S. et al., Altered microRNA expression in skeletal muscle results from high-fat diet-induced insulin resistance in mice. Mol. Med. Rep. 2012, 5, 1362-1368.
31. Gallagher, I. J., Scheele, C., Keller, P., Nielsen, A. R. et al., Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med. 2010, 2, 9.
32. Ofir, M., Hacohen, D., Ginsberg, D., Mir-15 and mir-16 are direct transcriptional targets of e2f1 that limit e2f-induced proliferation by targeting cyclin e. Mol. Cancer Res. 2011, 9, 440-447.
33. Bueno, M. J., Gomez de Cedron, M., Laresgoiti, U., Fernandez-Piqueras, J. et al., Multiple e2f-induced microRNAs prevent replicative stress in response to mitogenic signaling. Mol. Cell Biol. 2010, 30, 2983-2995.
34. Dimova, D. K., Dyson, N. J., The e2f transcriptional network: old acquaintances with new faces. Oncogene 2005, 24, 2810-2826.
35. Park, S., Choi, Y., Um, S. J., Yoon, S. K., Park, T., Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. J. Hepatol. 2011, 54, 984-993.
36. Cho, S., Choi, Y., Park, S., Park, T., Carvacrol prevents diet-induced obesity by modulating gene expressions involved in adipogenesis and inflammation in mice fed with high-fat diet. J. Nutr. Biochem. 2012, 23, 192-201.
37. Fajas, L., Landsberg, R. L., Huss-Garcia, Y., Sardet, C., et al., E2fs regulate adipocyte differentiation. Dev. Cell 2002, 3, 39-49.
38. Sadruddin, S., Arora, R., Resveratrol: biologic and therapeutic implications. J. Cardiometab. Syndr. 2009, 4, 102-106.
39. Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J. et al., Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 2003, 278, 34268-34276.
40. Moon, Y. A., Liang, G., Xie, X., Frank-Kamenetsky, M. et al., The scap/srebp pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab. 2012, 15, 240-246.
41. Um, M. Y., Moon, M. K., Ahn, J., Youl Ha, T., Coumarin attenuates hepatic steatosis by down-regulating lipogenic gene expression in mice fed a high-fat diet. Br. J. Nutr. 2013, 109, 1590-1597.
42. Derdak, Z., Villegas, K. A., Harb, R., Wu, A. M. et al., Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. J. Hepatol. 2013, 58, 785-791.
43. Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P. et al., MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27, 91-105.
44. Hibio, N., Hino, K., Shimizu, E., Nagata, Y., Ui-Tei, K., Stability of miRNA 5'terminal and seed regions is correlated with experimentally observed miRNA-mediated silencing efficacy. Sci. Rep. 2012, 2, 996.
45. Chi, S. W., Hannon, G. J., Darnell, R. B., An alternative mode of microRNA target recognition. Nat. Struct. Mol. Biol. 2012, 19, 321-327.
46. Khan, A. A., Betel, D., Miller, M. L., Sander, C. et al., Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol. 2009, 27, 549-555.
47. Cheng, C. J., Saltzman, W. M., Slack, F. J., Canonical and non-canonical barriers facing antimir cancer therapeutics. Curr. Med. Chem. 2013, 20, 3582-3593.
48. Stenvang, J., Petri, A., Lindow, M., Obad, S., Kauppinen, S., Inhibition of microRNA function by antimir oligonucleotides. Silence 2012, 3, 1.
49. Hullinger, T. G., Montgomery, R. L., Seto, A. G., Dickinson, B. A. et al., Inhibition of mir-15 protects against cardiac ischemic injury. Circ. Res. 2012, 110, 71-81.